Evidence map›Paper›PMID 40304597›Full record

ArticleCancer2025

Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in California.

Lena E Winestone, Juan Yang, Tanushree Banerjee, Meera Sangaramoorthy, Justine Kahn, Renata Abrahão, Theresa H Keegan, Iona Cheng, Scarlett Lin Gomez, Salma Shariff-Marco

Abstract read
In one paragraph

Article in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Interplay between Genetic Ancestry, Self-reported Race and Ethnicity, and Clinical Factors in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lena E WinestoneDivision of Allergy, Immunology, and BMT, UCSF Benioff Children's Hospitals, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-9982-1594
Juan YangReal World Evidence, Gilead Sciences, Inc., Foster City, California, USA.
Tanushree BanerjeeDivision of General Internal Medicine, Department of Medicine, University of California, San Francisco, California, USA.
Meera SangaramoorthyGreater Bay Area Cancer Registry, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-6839-3192
Justine KahnDivision of Pediatric Hematology/Oncology/Stem Cell Transplantation, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.ORCID https://orcid.org/0000-0003-3330-6754
Renata AbrahãoCenter for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
Theresa H KeeganCenter for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.ORCID https://orcid.org/0000-0002-1961-4008
Iona ChengUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
Scarlett Lin GomezUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-5143-4867
Salma Shariff-MarcoUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-2541-3333

Funding

American Cancer Society CSDG-21-093-01-HOPSLeukemia and Lymphoma SocietyNCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS SEER Contract HHSN261201800032I
6 · The paper itself

Abstract

introductionResidence in lower socioeconomic neighborhoods is associated with lower survival in children, adolescents, and young adults with leukemia. We sought to evaluate the impact of neighborhood archetypes on acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) survival.

methodsPatients aged 0 to 39 years diagnosed with ALL or AML from 2006 through 2016 in the California Cancer Registry were included. Nine-class neighborhood archetypes, generated by latent class analysis of 39 social and built environment attributes at the census tract level, were the primary exposure of interest. Cox proportional hazards models were used for statistical analyses, stratified by age.

resultsAmong 8776 patients, 72% had ALL and 28% had AML. For ALL, increased risk of mortality was observed in mixed socioeconomic status suburbs (adjusted hazard ratio, 1.39; 95% CI, 1.06-1.84) and Hispanic small towns (adjusted hazard ratio, 1.33; 95% CI, 1.03-1.84) relative to upper middle-class suburbs. For AML, neighborhood archetypes were not associated with mortality. When stratified by age, we observed associations between neighborhood archetypes (mixed socioeconomic status class suburb, inner city, Hispanic small towns) and mortality in pediatric but not young adult ALL patients.

conclusionsOur findings demonstrate that neighborhood archetypes efficiently account for complex interactions across social and built environment attributes with leukemia survival. The greater effects of neighborhood archetype in pediatric ALL survival, as compared to AML, may be related to the prolonged, outpatient nature of ALL maintenance therapy and the challenges associated with treatment adherence among patients residing in disadvantaged neighborhoods.

Indexed as

Leukemia, Myeloid, AcuteNeighborhood CharacteristicsPrecursor Cell Lymphoblastic Leukemia-LymphomaResidence CharacteristicsAdolescentAdultCaliforniaChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleProportional Hazards ModelsRegistriesAYA patientsdisparitiesleukemianeighborhoodoverall mortality

Identifiers

PMID40304597
PMCPMC12042787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.